Transfection of PD-L1-positive CHO cells with 28A10 × 2E4 resulted in the decreased NFκ-light-chain-enhancer of activated B-cell activities (NFκB, tumor-mediator), indicating its anti-tumor activity [136]. This evidence concerns the gene NFKB1 and neoplasm.